IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
: Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that fila...
Saved in:
Published in | Experimental dermatology Vol. 21; no. 2; pp. 104 - 110 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.02.2012
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | : Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures (P = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target. |
---|---|
AbstractList | : Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures (P = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target. Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL-17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin-17 (IL-17) on the expression of the protein and profilaggrin-processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin-17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin-17A-exposed cultures (P=0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL-17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target. Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by impairment in epidermal barrier function and abnormal IL‐17 expression in the skin and peripheral blood. Recent findings indicated that filaggrin is essential during barrier formation and its insufficiency underlies the pathogenesis of atopic eczema. Filaggrin downregulation has also been reported in psoriasis. It is clear that Th1/Th2 bias influences expression of the protein, but an analysis of the effects of interleukin‐17 (IL‐17) on the expression of the protein and profilaggrin‐processing enzymes has not yet been reported. In addition, the effect of the cytokine on components of functional epidermal barrier, tight junctions and adhesion/desmosomal proteins, has not been elucidated. Keratinocytes were exposed to interleukin‐17A, and microarray analysis was performed. Filaggrin protein level was assessed by western blot. We have observed a significant decrease in profilaggrin mRNA level in interleukin‐17A‐exposed cultures ( P = 0.008). Expression of processing enzymes was also altered, indicating an indirect effect of the cytokine on filaggrin production/degradation. Moreover, expression of many genes involved in cellular adhesion was also decreased. A significant downregulation of filaggrin at the protein level was detected by western blot in immortal and primary keratinocytes. Gene ontology analysis indicated changes in keratinization, epidermal differentiation and formation of the cornified envelope. We conclude that IL‐17A downregulates the expression of filaggrin and genes important for cellular adhesion which could affect epidermal barrier formation. This effect potentially contributes to barrier dysfunction and could become a possible therapeutic target. |
Author | Schaupp, Anna L. Gutowska-Owsiak, Danuta McPherson, Tess Salimi, Maryam Taylor, Stephen Ogg, Graham S. Selvakumar, Tharini A. |
Author_xml | – sequence: 1 givenname: Danuta surname: Gutowska-Owsiak fullname: Gutowska-Owsiak, Danuta organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 2 givenname: Anna L. surname: Schaupp fullname: Schaupp, Anna L. organization: Translational Gastroenterology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 3 givenname: Maryam surname: Salimi fullname: Salimi, Maryam organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 4 givenname: Tharini A. surname: Selvakumar fullname: Selvakumar, Tharini A. organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 5 givenname: Tess surname: McPherson fullname: McPherson, Tess organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 6 givenname: Stephen surname: Taylor fullname: Taylor, Stephen organization: Computational Biology Research Group, University of Oxford, John Radcliffe Hospital, Oxford, UK – sequence: 7 givenname: Graham S. surname: Ogg fullname: Ogg, Graham S. organization: MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, Oxford, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25579285$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22229441$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUFv0zAUxy00xLrBV0C-IHFJsB07Tg4c0DbGpAKXoSEuluM8d-5Su7NTtf32OLSUK-9iS_7933v6-QKd-eABIUxJSXN9WJa0JqQgNRMlI5SWhHLKyt0LNDs9nKEZaUld1JKIc3SR0pIQKispXqFzlqvlnM7QcDcvqMR92PoIi82gR0jYukEvFtF5rH2PtbVgxoSfIOrR-WD2I2DYrSOk5ILHweIF-BzTKQXjcoceb934iA0MQ-4Yse4fYUJfo5dWDwneHM9L9OPzzf3Vl2L-_fbu6tO8MIK2rKhAdy0XXBrObAPGEAENYxxYz1krhK11bzvBtJSWdz3IClra9Zm1NeetqS7R-0PfdQzPG0ijWrk0baM9hE1SVIqKS8oZyWhzQE0MKUWwah3dSse9okRNrtVSTUrVpFRNrtUf12qXo2-PUzbdCvpT8K_cDLw7AjoZPdiovXHpHyeEbFkjMvfxwG3dAPv_XkDd_LyebjlfHPIujbA75XV8UvX04erh261qfn1l9w_Ntaqr3yhSrD8 |
CitedBy_id | crossref_primary_10_1002_jev2_12335 crossref_primary_10_1016_j_det_2017_02_006 crossref_primary_10_1007_s13770_023_00532_1 crossref_primary_10_1016_j_xcrm_2023_101340 crossref_primary_10_1002_iub_1405 crossref_primary_10_1111_all_14488 crossref_primary_10_4161_21688370_2014_974451 crossref_primary_10_1007_s40674_015_0019_2 crossref_primary_10_1007_s11882_012_0293_0 crossref_primary_10_1016_j_jaad_2013_12_036 crossref_primary_10_1177_1203475417722552 crossref_primary_10_2174_1871530319666191129120253 crossref_primary_10_1097_ACI_0000000000000306 crossref_primary_10_1111_cea_13697 crossref_primary_10_1111_ced_14384 crossref_primary_10_1097_JD9_0000000000000155 crossref_primary_10_3109_08916934_2016_1166214 crossref_primary_10_1038_s41423_023_00992_4 crossref_primary_10_2217_imt_2016_0128 crossref_primary_10_1016_j_anai_2019_10_005 crossref_primary_10_21518_ms2024_017 crossref_primary_10_3389_fimmu_2021_764384 crossref_primary_10_1016_j_semarthrit_2013_04_006 crossref_primary_10_1080_25785826_2019_1642727 crossref_primary_10_2147_CCID_S462797 crossref_primary_10_3389_fmed_2024_1335551 crossref_primary_10_1007_s12016_014_8415_1 crossref_primary_10_1007_s40259_014_0098_x crossref_primary_10_1093_bjd_ljac039 crossref_primary_10_1016_j_yexcr_2017_09_004 crossref_primary_10_1016_S0151_9638_20_31082_6 crossref_primary_10_1111_1346_8138_15507 crossref_primary_10_1097_DAD_0000000000000378 crossref_primary_10_3390_jcm10245834 crossref_primary_10_1038_s41541_017_0014_8 crossref_primary_10_2147_DDDT_S240866 crossref_primary_10_1080_1744666X_2019_1564038 crossref_primary_10_1016_j_jphs_2021_09_006 crossref_primary_10_1111_bjd_14908 crossref_primary_10_1098_rsfs_2012_0090 crossref_primary_10_1111_vde_13125 crossref_primary_10_3390_jcm12041538 crossref_primary_10_3390_biomedicines10051183 crossref_primary_10_3892_ijmm_2015_2445 crossref_primary_10_1002_ptr_6061 crossref_primary_10_3390_ijms221910841 crossref_primary_10_1016_j_jddst_2024_105909 crossref_primary_10_1016_j_jaci_2016_02_008 crossref_primary_10_1016_j_bbamcr_2013_06_010 crossref_primary_10_1111_bjd_16487 crossref_primary_10_3390_ijms22115729 crossref_primary_10_1111_cpr_13441 crossref_primary_10_1111_exd_13808 crossref_primary_10_17816_dv607439 crossref_primary_10_1007_s00441_014_2096_1 crossref_primary_10_3390_ijms24097956 crossref_primary_10_1111_imm_12142 crossref_primary_10_3389_fimmu_2021_761890 crossref_primary_10_1038_s41598_017_15892_7 crossref_primary_10_1038_s41598_022_15393_2 crossref_primary_10_1016_j_dsi_2015_03_007 crossref_primary_10_1016_j_xjidi_2022_100131 crossref_primary_10_1111_j_1365_2133_2012_11099_x crossref_primary_10_1016_j_jaci_2024_04_009 crossref_primary_10_3390_ijms14046720 crossref_primary_10_1016_j_anai_2017_09_055 crossref_primary_10_1080_14712598_2020_1729736 crossref_primary_10_1111_exd_12554 crossref_primary_10_3389_fmolb_2022_917077 crossref_primary_10_3389_fimmu_2020_594735 crossref_primary_10_1016_j_anai_2018_11_015 crossref_primary_10_1038_s41598_017_00670_2 crossref_primary_10_1016_j_dsi_2012_07_003 crossref_primary_10_1089_ped_2014_0482 crossref_primary_10_25208_vdv1286 crossref_primary_10_3892_mmr_2017_7689 crossref_primary_10_1080_13543784_2024_2347294 crossref_primary_10_1007_s40744_017_0084_0 crossref_primary_10_1016_j_cytogfr_2017_09_005 crossref_primary_10_1097_DAD_0000000000002418 crossref_primary_10_1016_j_intimp_2022_108795 crossref_primary_10_1016_j_jaci_2014_06_014 crossref_primary_10_1016_j_jaci_2014_04_021 crossref_primary_10_1111_ddg_12812 crossref_primary_10_1111_ced_12567 crossref_primary_10_1111_ddg_80_12812 crossref_primary_10_3390_ijms232113498 crossref_primary_10_3390_cells12242793 crossref_primary_10_1097_ACI_0b013e32835af232 crossref_primary_10_1371_journal_pone_0288347 crossref_primary_10_17816_dv108870 crossref_primary_10_1126_scitranslmed_aad6833 crossref_primary_10_1016_j_jaci_2019_07_013 crossref_primary_10_1111_imr_12545 crossref_primary_10_1007_s00424_016_1903_9 crossref_primary_10_1111_cea_13897 crossref_primary_10_15570_actaapa_2022_3 crossref_primary_10_4049_jimmunol_1602185 crossref_primary_10_1111_jdv_12753 crossref_primary_10_12677_ACM_2023_134740 crossref_primary_10_2336_nishinihonhifu_75_399 crossref_primary_10_15690_vsp_v18i5_2064 crossref_primary_10_1016_j_jaci_2018_02_040 crossref_primary_10_1080_09546634_2021_1967268 crossref_primary_10_1016_j_piel_2015_04_011 crossref_primary_10_1007_s10067_015_2961_7 crossref_primary_10_3390_ijms17020244 crossref_primary_10_3390_ijms19103086 crossref_primary_10_3390_ijms20174070 crossref_primary_10_4168_aard_2020_8_1_9 crossref_primary_10_1007_s40265_014_0219_3 crossref_primary_10_1111_jdv_13619 crossref_primary_10_1007_s13233_023_00236_4 crossref_primary_10_1134_S1022795414100123 crossref_primary_10_1007_s10067_016_3350_6 crossref_primary_10_3390_ijms23105318 crossref_primary_10_1016_j_jaci_2015_04_026 crossref_primary_10_1016_j_jaci_2018_10_032 crossref_primary_10_1016_j_lfs_2013_07_027 crossref_primary_10_1016_j_piel_2018_01_010 crossref_primary_10_25208_0042_4609_2019_95_1_59_76 crossref_primary_10_1097_ACI_0b013e328364e8f7 crossref_primary_10_1016_j_jid_2016_07_043 crossref_primary_10_1016_j_jaci_2012_12_668 crossref_primary_10_4168_aair_2018_10_3_207 crossref_primary_10_1080_00914037_2023_2299801 crossref_primary_10_15789_1563_0625_IRI_2138 crossref_primary_10_1097_DER_0000000000000143 crossref_primary_10_1016_j_jaci_2015_01_048 crossref_primary_10_1111_dth_12787 crossref_primary_10_1007_s11882_014_0433_9 crossref_primary_10_3390_ijms21186484 crossref_primary_10_3389_fphar_2022_1067051 crossref_primary_10_1371_journal_pone_0161759 crossref_primary_10_1016_j_jconrel_2016_08_007 crossref_primary_10_1111_exd_14425 crossref_primary_10_1002_ski2_99 crossref_primary_10_3389_fimmu_2018_01682 crossref_primary_10_1111_cea_12023 crossref_primary_10_1016_j_jid_2016_12_032 crossref_primary_10_3906_vet_1507_26 crossref_primary_10_1016_j_redox_2020_101530 crossref_primary_10_1038_s41590_018_0256_2 crossref_primary_10_23902_trkjnat_878417 crossref_primary_10_3390_healthcare8020070 crossref_primary_10_1016_j_jdermsci_2013_02_001 crossref_primary_10_3390_ijms21155382 crossref_primary_10_1016_j_cbi_2022_110122 crossref_primary_10_1007_s40259_021_00490_x crossref_primary_10_1038_cdd_2017_56 crossref_primary_10_1111_1346_8138_15250 crossref_primary_10_1111_cod_12021 crossref_primary_10_21518_2079_701X_2022_16_3_130_136 crossref_primary_10_3389_fmed_2017_00119 crossref_primary_10_1111_cei_13449 crossref_primary_10_1016_j_det_2018_12_007 crossref_primary_10_1016_j_jid_2019_04_024 crossref_primary_10_1016_j_biopha_2021_112569 crossref_primary_10_1016_j_biopha_2020_111065 crossref_primary_10_1007_s12272_021_01305_x crossref_primary_10_1016_j_jid_2020_07_006 crossref_primary_10_1016_j_jaci_2017_01_011 crossref_primary_10_1016_j_jaci_2021_07_003 crossref_primary_10_3390_jcm10112506 |
Cites_doi | 10.1111/j.1365-2133.2006.07642.x 10.1016/j.jaci.2009.05.042 10.1016/j.jaad.2010.09.714 10.1038/ng1767 10.1038/jid.2008.280 10.1159/000314366 10.1111/1523-1747.ep12466185 10.1038/sj.jid.5700720 10.1084/jem.20071094 10.1038/jid.2008.29 10.1093/bioinformatics/btn224 10.1016/j.jaci.2007.04.031 10.1128/IAI.00958-10 10.1038/jid.2008.413 10.1038/sj.jid.5701213 10.1111/j.1398-9995.2010.02493.x 10.4049/jimmunol.179.7.4313 10.1111/j.1365-2133.2010.10068.x 10.1038/jid.2008.283 10.1111/j.1365-2133.2005.06352.x 10.1038/jid.2010.277 10.1046/j.0022-202x.2001.01493.x 10.1046/j.1523-1747.1998.00347.x 10.1038/sj.jid.5700817 10.1186/1471-2105-10-48 10.1067/mai.2000.110159 10.1002/eji.200939473 10.1111/j.1398-9995.1997.tb02158.x 10.1111/j.0022-202X.2005.23762.x 10.1111/j.1365-2133.2010.09866.x 10.1016/0167-4838(83)90336-9 10.1016/j.jaci.2008.10.031 10.1111/j.0906-6705.2005.00338.x 10.1111/j.1600-0625.2008.00786.x 10.1111/j.1600-0625.2009.00902.x 10.1038/jid.2009.399 10.1074/jbc.M409026200 10.1136/bmj.b2433 10.2353/ajpath.2009.080973 10.1038/sj.jid.5700582 10.1111/j.1600-0625.2006.00539.x 10.1016/j.jaci.2009.12.934 10.1016/j.jaci.2007.12.1161 10.1046/j.1365-2133.1999.03038.x 10.1097/01.LAB.0000036874.83540.2B 10.1046/j.1523-1747.2000.00041.x 10.1016/j.jdermsci.2008.12.011 10.1016/j.jaci.2009.07.040 10.1016/j.jaci.2011.01.031 10.1189/JLB.0109046 10.1097/ACI.0b013e3282ef869e 10.1038/jid.2010.175 10.1080/00015550050500077 10.1016/j.arcmed.2005.07.003 10.4049/jimmunol.181.10.7420 10.2174/156652408785160952 10.2353/ajpath.2007.061067 10.1016/j.bbamem.2008.08.027 10.2202/1544-6115.1027 10.1111/j.1600-0625.2006.00478.x 10.1111/j.1365-2133.2005.06989.x 10.1016/j.jaci.2010.10.018 10.1007/s12016-007-0042-7 10.1159/000250218 10.1038/jid.2011.24 10.1111/j.1365-2133.2009.09582.x 10.1111/j.0022-202X.2005.23935.x 10.1002/path.2200 10.1073/pnas.0706942104 10.1016/j.jaci.2003.08.049 10.1016/j.jaci.2009.09.031 10.1016/j.jaci.2009.03.041 10.1007/s004030100221 10.1111/j.1346-8138.2004.tb00672.x 10.1038/jid.2008.111 10.1111/j.1600-0625.2011.01280.x 10.1038/jid.2010.307 10.1067/mai.2003.1414 |
ContentType | Journal Article |
Copyright | 2011 John Wiley & Sons A/S 2015 INIST-CNRS 2011 John Wiley & Sons A/S. |
Copyright_xml | – notice: 2011 John Wiley & Sons A/S – notice: 2015 INIST-CNRS – notice: 2011 John Wiley & Sons A/S. |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FD FR3 P64 RC3 |
DOI | 10.1111/j.1600-0625.2011.01412.x |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Genetics Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0625 |
EndPage | 110 |
ExternalDocumentID | 10_1111_j_1600_0625_2011_01412_x 22229441 25579285 EXD1412 ark_67375_WNG_8ZM2TW8D_6 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Medical Research Council grantid: MC_U137881017 – fundername: Medical Research Council grantid: G0701693 – fundername: Medical Research Council |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAJUZ AAVGM ABCVL ABHUG ABPTK ACXME ADAWD ADDAD AFVGU AGJLS IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FD FR3 P64 RC3 |
ID | FETCH-LOGICAL-c5192-3eab94547c42f8ecc05e8224e2d42955f6adfb52a77f4bde73e91bd2f8f6449c3 |
IEDL.DBID | DR2 |
ISSN | 0906-6705 |
IngestDate | Fri Aug 16 12:14:28 EDT 2024 Fri Aug 23 00:33:13 EDT 2024 Sat Sep 28 08:35:27 EDT 2024 Tue Jan 23 04:49:25 EST 2024 Sat Aug 24 00:53:50 EDT 2024 Wed Oct 30 09:53:32 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Allergy Immunopathology Skin disease Dermatology keratinocytes Adhesion atopic eczema Interleukin 17 Atopy Eczema IL-17 Keratinocyte epidermal barrier filaggrin |
Language | English |
License | CC BY 4.0 2011 John Wiley & Sons A/S. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5192-3eab94547c42f8ecc05e8224e2d42955f6adfb52a77f4bde73e91bd2f8f6449c3 |
Notes | istex:4423AED045EC8FC3E2950D3B9EE5B367A525DD79 ark:/67375/WNG-8ZM2TW8D-6 ArticleID:EXD1412 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0625.2011.01412.x |
PMID | 22229441 |
PQID | 1753471420 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1753471420 crossref_primary_10_1111_j_1600_0625_2011_01412_x pubmed_primary_22229441 pascalfrancis_primary_25579285 wiley_primary_10_1111_j_1600_0625_2011_01412_x_EXD1412 istex_primary_ark_67375_WNG_8ZM2TW8D_6 |
PublicationCentury | 2000 |
PublicationDate | February 2012 |
PublicationDateYYYYMMDD | 2012-02-01 |
PublicationDate_xml | – month: 02 year: 2012 text: February 2012 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Denmark |
PublicationTitle | Experimental dermatology |
PublicationTitleAlternate | Exp Dermatol |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | Capaldo C T, Nusrat A. Biochim Biophys Acta 2009: 1788: 864-871 [Review]. Di Cesare A, Di Meglio P, Nestle F O. J Invest Dermatol 2008: 128: 2569-2571. Milovanovic M, Drozdenko G, Weise C et al. J Invest Dermatol 2010: 130: 2621-2628. Harris T J, Grosso J F, Yen H R et al. J Immunol 2007: 7: 4313-4317. Yoshida Y, Morita K, Mizoguchi A et al. Arch Dermatol Res 2001: 293: 239-244. Lynley A M, Dale B A. Biochim Biophys Acta 1983: 1: 28-35. van den Oord R A, Sheikh A. BMJ 2009: 339: b2433. Ma H L, Liang S, Li J et al. J Clin Invest 2008: 118: 597-607. van Beelen A J, Teunissen M B, Kapsenberg M L et al. Curr Opin Allergy Clin Immunol 2007: 7: 374-381. Dai Y S. Clin Rev Allergy Immunol 2007: 33: 157-166. Nograles K E, Suarez-Farinas M, Shemer A et al. J Allergy Clin Immunol 2010: 125: 744-746, 746 e1-e2. Olaiwan A, Chandesris M O, Fraitag S et al. J Am Acad Dermatol 2011: 65: 1167-1172. He R, Kim H Y, Yoon J et al. J Allergy Clin Immunol 2009: 124: 761-770, 770 e1. Beck L A, Leung D Y. J Allergy Clin Immunol 2000: 106 (Suppl 5): S258-S263 [review]. Du P, Kibbe W A, Lin S M. Bioinformatics 2008: 24: 1547-1548. Koga C, Kabashima K, Shiraishi N et al. J Invest Dermatol 2008: 128: 2625-2630. Mee J B, Johnson C M, Morar N et al. Am J Pathol 2007: 171: 32-42. Negosanti M, Fanti P A, Gasponi A et al. Dermatologica 1981: 163: 474-475. Noh M, Yeo H, Ko J et al. Exp Dermatol 2010: 19: 355-362. Palmer C N, Irvine A D, Terron-Kwiatkowski A et al. Nat Genet 2006: 38: 441-446. Flohr C, England K, Radulovic S et al. Br J Dermatol 2010: 163: 1333-1336. Ovcina-Kurtovic N, Kasumagic-Halilovic E. Med Arh 2010: 64: 28-29. Watson R E, Poddar R, Walker J M et al. J Pathol 2007: 212: 450-458. Kotsimbos T C, Ernst P, Hamid Q A. Proc Assoc Am Physicians 1996: 108: 368-373. Kagami S, Rizzo H L, Lee J J et al. J Invest Dermatol 2010: 130: 1373-1383. Itoh K, Kawasaki S, Kawamoto S et al. Exp Dermatol 2005: 14: 667-674. Smyth G K. Stat Appl Genet Mol Biol 2004: 3: Article3. Takaishi M, Makino T, Morohashi M et al. J Biol Chem 2005: 6: 4696-4703. Horikoshi T, Igarashi S, Uchiwa H et al. Br J Dermatol 1999: 141: 453-459. Jensen J M, Proksch E. G Ital Dermatol Venereol 2009: 144: 689-700. Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A et al. J Allergy Clin Immunol 2009: 124: 1235-1244. Niebuhr M, Gathmann M, Scharonow H et al. Infect Immun 2011: 79: 1615-1622 [Epub 2011 Jan 18]. Gupta J, Grube E, Ericksen M B et al. J Allergy Clin Immunol 2008: 121: 725-730, 730 e2. Chung E, Cook P W, Parkos C A et al. J Invest Dermatol 2005: 124: 1134-1140. Zhang H, Guo Y, Wang W et al. Allergy 2011: 66: 420-427. Niebuhr M, Gathmann M, Scharonow H et al. Infect Immun 2011: 79: 1615-1622. Guttman-Yassky E, Lowes M A, Fuentes-Duculan J et al. J Immunol 2008: 10: 7420-7427. Iizuka H, Takahashi H, Honma M et al. J Dermatol 2004: 31: 271-276. Akiyama M. Br J Dermatol 2010: 162: 472-477. Howell M D, Kim B E, Gao P et al. J Allergy Clin Immunol 2007: 120: 150-155. McPherson T, Sherman V J, Aslam A et al. Br J Dermatol 2010: 3: 544-549. He R, Oyoshi M K, Jin H et al. Proc Natl Acad Sci U S A 2007: 40: 15817-15822. Nomura I, Gao B, Boguniewicz M et al. J Allergy Clin Immunol 2003: 112: 1195-1202. Albanesi C, Scarponi C, Cavani A et al. J Invest Dermatol 2000: 115: 81-87. Nograles K E, Zaba L C, Shemer A et al. J Allergy Clin Immunol 2009: 123: 1244-1252, 1252 e2. Nemoto-Hasebe I, Akiyama M, Nomura T et al. J Invest Dermatol 2009: 129: 682-689. Barnes P J. Curr Mol Med 2008: 8: 330-334. Peltonen S, Riehokainen J, Pummi K et al. Br J Dermatol 2007: 156: 466-472. Kim B E, Howell M D, Guttman E et al. J Invest Dermatol 2011: 131: 1272-1279. Kirschner N, Poetzl C, von den Driesch P et al. Am J Pathol 2009: 175: 1095-1106. Zhao Y, Terron-Kwiatkowski A, Liao H et al. J Invest Dermatol 2007: 127: 1878-1882. Gabrielsson S, Paulie S, Roquet A et al. Allergy 1997: 52: 860-865. Bottema R W, Nolte I M, Howard T D et al. Int Arch Allergy Immunol 2010: 153: 259-267. Dale B A, Gown A M, Fleckman P et al. J Invest Dermatol 1987: 88: 306-313. Teunissen M B, Koomen C W, de Waal Malefyt R et al. J Invest Dermatol 1998: 111: 645-649. Hvid M, Vestergaard C, Kemp K et al. J Invest Dermatol 2011: 131: 150-157. Wang L F, Chiu H C, Hsu C J et al. J Dermatol Sci 2009: 54: 192-197. Huffmeier U, Traupe H, Oji V et al. J Invest Dermatol 2007: 127: 1367-1370. Proksch E, Brandner J M, Jensen J M. Exp Dermatol 2008: 17: 1063-1072. Ortega C, Fernandez A S, Carrillo J M et al. J Leukoc Biol 2009: 86: 435-443. Pigatto P D. Acta Derm Venereol Suppl (Stockh) 2000: 211: 19-20. Toda M, Leung D Y, Molet S et al. J Allergy Clin Immunol 2003: 111: 875-881. de Jongh C M, Jakasa I, Verberk M M et al. Br J Dermatol 2006: 154: 651-657. Yuki T, Haratake A, Koishikawa H et al. Exp Dermatol 2007: 16: 324-330. Kezic S, Kemperman P M, Koster E S et al. J Invest Dermatol 2008: 128: 2117-2119. Jakasa I, Verberk M M, Esposito M et al. J Invest Dermatol 2007: 127: 129-134. de Jongh G J, Zeeuwen P L, Kucharekova M et al. J Invest Dermatol 2005: 125: 1163-1173. Jakasa I, Verberk M M, Bunge A L et al. Exp Dermatol 2006: 15: 801-807. Hvid M, Johansen C, Deleuran B et al. Exp Dermatol 2011: 20: 633-636. Oyoshi M K, Murphy G F, Geha R S. J Allergy Clin Immunol 2009: 124: 485-493, 493 e1. Hata M, Tokura Y, Takigawa M et al. Lab Invest 2002: 82: 1451-1461. Brown S J, Asai Y, Cordell H J et al. J Allergy Clin Immunol 2011: 127: 661-667. Pummi K, Malminen M, Aho H et al. J Invest Dermat 2001: 117: 1050-1058. De Benedetto A, Rafaels N M, McGirt L Y et al. J Allergy Clin Immunol 2011: 127: 773-786, 786 e7. Sugiura H, Ebise H, Tazawa T et al. Br J Dermatol 2005: 152: 146-149. Eyerich K, Pennino D, Scarponi C et al. J Allergy Clin Immunol 2009: 123: 59-66, 66 e4. Eden E, Navon R, Steinfeld I et al. BMC Bioinformatics 2009: 10: 48. Lemini-Lopez A, Flores-Romo L, Arevalo-Lopez A et al. Arch Med Res 2006: 37: 36-44. Jakasa I, Koster E S, Calkoen F et al. J Invest Dermatol 2011: 131: 540-542. Lowes M A, Kikuchi T, Fuentes-Duculan J et al. J Invest Dermatol 2008: 128: 1207-1211. Tohyama M, Hanakawa Y, Shirakata Y et al. Eur J Immunol 2009: 39: 2779-2788. Zaba L C, Cardinale I, Gilleaudeau P et al. J Exp Med 2007: 13: 3183-3194. Fedi A M, Leoncini P, Farella V et al. G Ital Dermatol Venereol 1989: 124: 141-145. Brown S J, McLean W H. J Invest Dermatol 2009: 129: 543-552. 2009; 86 2010; 19 1983; 1 2006; 38 2006; 37 2004; 3 2008; 8 2000; 211 1998; 111 2007; 33 2003; 112 1996; 108 2003; 111 2011; 127 1987; 88 2007; 212 2004; 31 2010; 64 2001; 293 2009; 10 2009; 54 1997; 52 2007; 171 2011; 20 2011; 66 2009; 123 2008; 118 2010; 153 2008; 24 2009; 124 2007; 7 2011; 65 2009; 129 2010; 3 2009; 1788 2007; 127 2005; 152 2000; 115 2010; 125 1981; 163 2006; 15 2008; 17 2007; 120 2010; 163 2006; 154 2008; 128 1999; 141 2008; 10 2011; 79 2010; 162 2002; 82 2009; 175 2009; 339 2008; 121 2007; 13 2011; 131 2007; 16 2007; 156 1989; 124 2005; 124 2000; 106 2005; 125 2009; 144 2010; 130 2005; 6 2007; 40 2001; 117 2009; 39 2005; 14 e_1_2_7_5_2 e_1_2_7_3_2 e_1_2_7_9_2 e_1_2_7_7_2 e_1_2_7_19_2 e_1_2_7_83_2 e_1_2_7_15_2 e_1_2_7_60_2 e_1_2_7_81_2 e_1_2_7_13_2 e_1_2_7_41_2 e_1_2_7_62_2 e_1_2_7_11_2 e_1_2_7_43_2 e_1_2_7_64_2 e_1_2_7_85_2 e_1_2_7_45_2 e_1_2_7_66_2 e_1_2_7_47_2 e_1_2_7_68_2 e_1_2_7_26_2 e_1_2_7_49_2 Fedi A M (e_1_2_7_79_2) 1989; 124 Jensen J M (e_1_2_7_17_2) 2009; 144 e_1_2_7_50_2 e_1_2_7_25_2 e_1_2_7_52_2 e_1_2_7_75_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_54_2 e_1_2_7_73_2 e_1_2_7_21_2 e_1_2_7_33_2 e_1_2_7_56_2 e_1_2_7_35_2 e_1_2_7_58_2 e_1_2_7_77_2 e_1_2_7_37_2 e_1_2_7_39_2 e_1_2_7_4_2 e_1_2_7_2_2 e_1_2_7_8_2 e_1_2_7_6_2 e_1_2_7_18_2 e_1_2_7_82_2 e_1_2_7_16_2 e_1_2_7_61_2 e_1_2_7_80_2 e_1_2_7_14_2 e_1_2_7_40_2 e_1_2_7_63_2 e_1_2_7_12_2 e_1_2_7_42_2 e_1_2_7_65_2 e_1_2_7_10_2 e_1_2_7_44_2 e_1_2_7_67_2 e_1_2_7_46_2 e_1_2_7_69_2 e_1_2_7_48_2 e_1_2_7_27_2 e_1_2_7_29_2 e_1_2_7_72_2 Ovcina‐Kurtovic N (e_1_2_7_84_2) 2010; 64 e_1_2_7_70_2 e_1_2_7_24_2 e_1_2_7_30_2 e_1_2_7_51_2 e_1_2_7_76_2 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_53_2 e_1_2_7_74_2 e_1_2_7_20_2 e_1_2_7_34_2 e_1_2_7_55_2 e_1_2_7_36_2 e_1_2_7_57_2 Ma H L (e_1_2_7_71_2) 2008; 118 e_1_2_7_78_2 e_1_2_7_38_2 e_1_2_7_59_2 Kotsimbos T C (e_1_2_7_28_2) 1996; 108 |
References_xml | – volume: 108 start-page: 368 year: 1996 end-page: 373 publication-title: Proc Assoc Am Physicians – volume: 293 start-page: 239 year: 2001 end-page: 244 publication-title: Arch Dermatol Res – volume: 15 start-page: 801 year: 2006 end-page: 807 publication-title: Exp Dermatol – volume: 128 start-page: 2569 year: 2008 end-page: 2571 publication-title: J Invest Dermatol – volume: 10 start-page: 48 year: 2009 publication-title: BMC Bioinformatics – volume: 121 start-page: 725 year: 2008 end-page: 730 publication-title: J Allergy Clin Immunol – volume: 8 start-page: 330 year: 2008 end-page: 334 publication-title: Curr Mol Med – volume: 124 start-page: 1235 year: 2009 end-page: 1244 publication-title: J Allergy Clin Immunol – volume: 163 start-page: 1333 year: 2010 end-page: 1336 publication-title: Br J Dermatol – volume: 129 start-page: 682 year: 2009 end-page: 689 publication-title: J Invest Dermatol – volume: 127 start-page: 1367 year: 2007 end-page: 1370 publication-title: J Invest Dermatol – volume: 3 start-page: 544 year: 2010 end-page: 549 publication-title: Br J Dermatol – volume: 111 start-page: 875 year: 2003 end-page: 881 publication-title: J Allergy Clin Immunol – volume: 130 start-page: 1373 year: 2010 end-page: 1383 publication-title: J Invest Dermatol – volume: 40 start-page: 15817 year: 2007 end-page: 15822 publication-title: Proc Natl Acad Sci U S A – volume: 127 start-page: 661 year: 2011 end-page: 667 publication-title: J Allergy Clin Immunol – volume: 125 start-page: 1163 year: 2005 end-page: 1173 publication-title: J Invest Dermatol – volume: 65 start-page: 1167 year: 2011 end-page: 1172 publication-title: J Am Acad Dermatol – volume: 64 start-page: 28 year: 2010 end-page: 29 publication-title: Med Arh – volume: 128 start-page: 1207 year: 2008 end-page: 1211 publication-title: J Invest Dermatol – volume: 163 start-page: 474 year: 1981 end-page: 475 publication-title: Dermatologica – volume: 7 start-page: 4313 year: 2007 end-page: 4317 publication-title: J Immunol – volume: 118 start-page: 597 year: 2008 end-page: 607 publication-title: J Clin Invest – volume: 124 start-page: 761 year: 2009 end-page: 770 publication-title: J Allergy Clin Immunol – volume: 117 start-page: 1050 year: 2001 end-page: 1058 publication-title: J Invest Dermat – volume: 212 start-page: 450 year: 2007 end-page: 458 publication-title: J Pathol – volume: 127 start-page: 129 year: 2007 end-page: 134 publication-title: J Invest Dermatol – volume: 16 start-page: 324 year: 2007 end-page: 330 publication-title: Exp Dermatol – volume: 123 start-page: 59 year: 2009 end-page: 66 publication-title: J Allergy Clin Immunol – volume: 141 start-page: 453 year: 1999 end-page: 459 publication-title: Br J Dermatol – volume: 3 start-page: Article3 year: 2004 publication-title: Stat Appl Genet Mol Biol – volume: 106 start-page: S258 issue: Suppl 5 year: 2000 end-page: S263 publication-title: J Allergy Clin Immunol – volume: 127 start-page: 1878 year: 2007 end-page: 1882 publication-title: J Invest Dermatol – volume: 131 start-page: 540 year: 2011 end-page: 542 publication-title: J Invest Dermatol – volume: 131 start-page: 1272 year: 2011 end-page: 1279 publication-title: J Invest Dermatol – volume: 162 start-page: 472 year: 2010 end-page: 477 publication-title: Br J Dermatol – volume: 154 start-page: 651 year: 2006 end-page: 657 publication-title: Br J Dermatol – volume: 120 start-page: 150 year: 2007 end-page: 155 publication-title: J Allergy Clin Immunol – volume: 128 start-page: 2625 year: 2008 end-page: 2630 publication-title: J Invest Dermatol – volume: 124 start-page: 485 year: 2009 end-page: 493 publication-title: J Allergy Clin Immunol – volume: 13 start-page: 3183 year: 2007 end-page: 3194 publication-title: J Exp Med – volume: 82 start-page: 1451 year: 2002 end-page: 1461 publication-title: Lab Invest – volume: 6 start-page: 4696 year: 2005 end-page: 4703 publication-title: J Biol Chem – volume: 171 start-page: 32 year: 2007 end-page: 42 publication-title: Am J Pathol – volume: 66 start-page: 420 year: 2011 end-page: 427 publication-title: Allergy – volume: 124 start-page: 141 year: 1989 end-page: 145 publication-title: G Ital Dermatol Venereol – volume: 128 start-page: 2117 year: 2008 end-page: 2119 publication-title: J Invest Dermatol – volume: 129 start-page: 543 year: 2009 end-page: 552 publication-title: J Invest Dermatol – volume: 127 start-page: 773 year: 2011 end-page: 786 publication-title: J Allergy Clin Immunol – volume: 131 start-page: 150 year: 2011 end-page: 157 publication-title: J Invest Dermatol – volume: 20 start-page: 633 year: 2011 end-page: 636 publication-title: Exp Dermatol – volume: 7 start-page: 374 year: 2007 end-page: 381 publication-title: Curr Opin Allergy Clin Immunol – volume: 144 start-page: 689 year: 2009 end-page: 700 publication-title: G Ital Dermatol Venereol – volume: 39 start-page: 2779 year: 2009 end-page: 2788 publication-title: Eur J Immunol – volume: 1 start-page: 28 year: 1983 end-page: 35 publication-title: Biochim Biophys Acta – volume: 339 start-page: b2433 year: 2009 publication-title: BMJ – volume: 1788 start-page: 864 year: 2009 end-page: 871 publication-title: Biochim Biophys Acta – volume: 152 start-page: 146 year: 2005 end-page: 149 publication-title: Br J Dermatol – volume: 153 start-page: 259 year: 2010 end-page: 267 publication-title: Int Arch Allergy Immunol – volume: 24 start-page: 1547 year: 2008 end-page: 1548 publication-title: Bioinformatics – volume: 38 start-page: 441 year: 2006 end-page: 446 publication-title: Nat Genet – volume: 156 start-page: 466 year: 2007 end-page: 472 publication-title: Br J Dermatol – volume: 14 start-page: 667 year: 2005 end-page: 674 publication-title: Exp Dermatol – volume: 130 start-page: 2621 year: 2010 end-page: 2628 publication-title: J Invest Dermatol – volume: 124 start-page: 1134 year: 2005 end-page: 1140 publication-title: J Invest Dermatol – volume: 88 start-page: 306 year: 1987 end-page: 313 publication-title: J Invest Dermatol – volume: 17 start-page: 1063 year: 2008 end-page: 1072 publication-title: Exp Dermatol – volume: 112 start-page: 1195 year: 2003 end-page: 1202 publication-title: J Allergy Clin Immunol – volume: 37 start-page: 36 year: 2006 end-page: 44 publication-title: Arch Med Res – volume: 54 start-page: 192 year: 2009 end-page: 197 publication-title: J Dermatol Sci – volume: 33 start-page: 157 year: 2007 end-page: 166 publication-title: Clin Rev Allergy Immunol – volume: 86 start-page: 435 year: 2009 end-page: 443 publication-title: J Leukoc Biol – volume: 123 start-page: 1244 year: 2009 end-page: 1252 publication-title: J Allergy Clin Immunol – volume: 31 start-page: 271 year: 2004 end-page: 276 publication-title: J Dermatol – volume: 115 start-page: 81 year: 2000 end-page: 87 publication-title: J Invest Dermatol – volume: 19 start-page: 355 year: 2010 end-page: 362 publication-title: Exp Dermatol – volume: 211 start-page: 19 year: 2000 end-page: 20 publication-title: Acta Derm Venereol Suppl (Stockh) – volume: 79 start-page: 1615 year: 2011 end-page: 1622 publication-title: Infect Immun – volume: 111 start-page: 645 year: 1998 end-page: 649 publication-title: J Invest Dermatol – volume: 10 start-page: 7420 year: 2008 end-page: 7427 publication-title: J Immunol – volume: 52 start-page: 860 year: 1997 end-page: 865 publication-title: Allergy – volume: 175 start-page: 1095 year: 2009 end-page: 1106 publication-title: Am J Pathol – volume: 125 start-page: 744 year: 2010 end-page: 746 publication-title: J Allergy Clin Immunol – ident: e_1_2_7_33_2 doi: 10.1111/j.1365-2133.2006.07642.x – ident: e_1_2_7_70_2 doi: 10.1016/j.jaci.2009.05.042 – ident: e_1_2_7_78_2 doi: 10.1016/j.jaad.2010.09.714 – ident: e_1_2_7_2_2 doi: 10.1038/ng1767 – ident: e_1_2_7_10_2 doi: 10.1038/jid.2008.280 – ident: e_1_2_7_26_2 doi: 10.1159/000314366 – ident: e_1_2_7_53_2 doi: 10.1111/1523-1747.ep12466185 – ident: e_1_2_7_80_2 doi: 10.1038/sj.jid.5700720 – ident: e_1_2_7_56_2 doi: 10.1084/jem.20071094 – volume: 64 start-page: 28 year: 2010 ident: e_1_2_7_84_2 publication-title: Med Arh contributor: fullname: Ovcina‐Kurtovic N – ident: e_1_2_7_6_2 doi: 10.1038/jid.2008.29 – ident: e_1_2_7_47_2 doi: 10.1093/bioinformatics/btn224 – volume: 124 start-page: 141 year: 1989 ident: e_1_2_7_79_2 publication-title: G Ital Dermatol Venereol contributor: fullname: Fedi A M – ident: e_1_2_7_23_2 doi: 10.1016/j.jaci.2007.04.031 – ident: e_1_2_7_65_2 doi: 10.1128/IAI.00958-10 – ident: e_1_2_7_8_2 doi: 10.1038/jid.2008.413 – ident: e_1_2_7_40_2 doi: 10.1038/sj.jid.5701213 – ident: e_1_2_7_4_2 doi: 10.1111/j.1398-9995.2010.02493.x – ident: e_1_2_7_77_2 doi: 10.4049/jimmunol.179.7.4313 – ident: e_1_2_7_3_2 doi: 10.1111/j.1365-2133.2010.10068.x – ident: e_1_2_7_46_2 doi: 10.1038/jid.2008.283 – ident: e_1_2_7_59_2 doi: 10.1111/j.1365-2133.2005.06352.x – ident: e_1_2_7_75_2 doi: 10.1128/IAI.00958-10 – ident: e_1_2_7_67_2 doi: 10.1038/jid.2010.277 – ident: e_1_2_7_34_2 doi: 10.1046/j.0022-202x.2001.01493.x – ident: e_1_2_7_55_2 doi: 10.1046/j.1523-1747.1998.00347.x – ident: e_1_2_7_82_2 doi: 10.1038/sj.jid.5700817 – ident: e_1_2_7_49_2 doi: 10.1186/1471-2105-10-48 – ident: e_1_2_7_19_2 doi: 10.1067/mai.2000.110159 – ident: e_1_2_7_57_2 doi: 10.1002/eji.200939473 – ident: e_1_2_7_27_2 doi: 10.1111/j.1398-9995.1997.tb02158.x – volume: 108 start-page: 368 year: 1996 ident: e_1_2_7_28_2 publication-title: Proc Assoc Am Physicians contributor: fullname: Kotsimbos T C – ident: e_1_2_7_30_2 doi: 10.1111/j.0022-202X.2005.23762.x – ident: e_1_2_7_21_2 doi: 10.1111/j.1365-2133.2010.09866.x – ident: e_1_2_7_5_2 doi: 10.1016/0167-4838(83)90336-9 – ident: e_1_2_7_39_2 doi: 10.1016/j.jaci.2008.10.031 – ident: e_1_2_7_69_2 doi: 10.1111/j.0906-6705.2005.00338.x – ident: e_1_2_7_18_2 doi: 10.1111/j.1600-0625.2008.00786.x – ident: e_1_2_7_68_2 doi: 10.1111/j.1600-0625.2009.00902.x – ident: e_1_2_7_43_2 doi: 10.1038/jid.2009.399 – ident: e_1_2_7_81_2 doi: 10.1074/jbc.M409026200 – ident: e_1_2_7_9_2 doi: 10.1136/bmj.b2433 – ident: e_1_2_7_31_2 doi: 10.2353/ajpath.2009.080973 – ident: e_1_2_7_16_2 doi: 10.1038/sj.jid.5700582 – volume: 144 start-page: 689 year: 2009 ident: e_1_2_7_17_2 publication-title: G Ital Dermatol Venereol contributor: fullname: Jensen J M – ident: e_1_2_7_51_2 doi: 10.1111/j.1600-0625.2006.00539.x – ident: e_1_2_7_58_2 doi: 10.1016/j.jaci.2009.12.934 – ident: e_1_2_7_13_2 doi: 10.1016/j.jaci.2007.12.1161 – ident: e_1_2_7_50_2 doi: 10.1046/j.1365-2133.1999.03038.x – ident: e_1_2_7_14_2 doi: 10.1097/01.LAB.0000036874.83540.2B – ident: e_1_2_7_38_2 doi: 10.1046/j.1523-1747.2000.00041.x – ident: e_1_2_7_72_2 doi: 10.1016/j.jdermsci.2008.12.011 – ident: e_1_2_7_74_2 doi: 10.1016/j.jaci.2009.07.040 – ident: e_1_2_7_22_2 doi: 10.1016/j.jaci.2011.01.031 – ident: e_1_2_7_54_2 doi: 10.1189/JLB.0109046 – ident: e_1_2_7_64_2 doi: 10.1097/ACI.0b013e3282ef869e – ident: e_1_2_7_76_2 doi: 10.1038/jid.2010.175 – ident: e_1_2_7_85_2 doi: 10.1080/00015550050500077 – ident: e_1_2_7_32_2 doi: 10.1016/j.arcmed.2005.07.003 – ident: e_1_2_7_44_2 doi: 10.4049/jimmunol.181.10.7420 – ident: e_1_2_7_25_2 doi: 10.2174/156652408785160952 – ident: e_1_2_7_61_2 doi: 10.2353/ajpath.2007.061067 – ident: e_1_2_7_29_2 doi: 10.1016/j.bbamem.2008.08.027 – ident: e_1_2_7_48_2 doi: 10.2202/1544-6115.1027 – ident: e_1_2_7_15_2 doi: 10.1111/j.1600-0625.2006.00478.x – ident: e_1_2_7_12_2 doi: 10.1111/j.1365-2133.2005.06989.x – ident: e_1_2_7_37_2 doi: 10.1016/j.jaci.2010.10.018 – ident: e_1_2_7_20_2 doi: 10.1007/s12016-007-0042-7 – ident: e_1_2_7_83_2 doi: 10.1159/000250218 – ident: e_1_2_7_24_2 doi: 10.1038/jid.2011.24 – ident: e_1_2_7_7_2 doi: 10.1111/j.1365-2133.2009.09582.x – ident: e_1_2_7_63_2 doi: 10.1111/j.0022-202X.2005.23935.x – ident: e_1_2_7_35_2 doi: 10.1002/path.2200 – ident: e_1_2_7_73_2 doi: 10.1073/pnas.0706942104 – ident: e_1_2_7_60_2 doi: 10.1016/j.jaci.2003.08.049 – volume: 118 start-page: 597 year: 2008 ident: e_1_2_7_71_2 publication-title: J Clin Invest contributor: fullname: Ma H L – ident: e_1_2_7_62_2 doi: 10.1016/j.jaci.2009.09.031 – ident: e_1_2_7_45_2 doi: 10.1016/j.jaci.2009.03.041 – ident: e_1_2_7_36_2 doi: 10.1007/s004030100221 – ident: e_1_2_7_52_2 doi: 10.1111/j.1346-8138.2004.tb00672.x – ident: e_1_2_7_42_2 doi: 10.1038/jid.2008.111 – ident: e_1_2_7_66_2 doi: 10.1111/j.1600-0625.2011.01280.x – ident: e_1_2_7_11_2 doi: 10.1038/jid.2010.307 – ident: e_1_2_7_41_2 doi: 10.1067/mai.2003.1414 |
SSID | ssj0017375 |
Score | 2.4594789 |
Snippet | : Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by... Atopic eczema and psoriasis are common skin diseases. While it is well established that the pathogenesis of these diseases varies, both are characterized by... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 104 |
SubjectTerms | Allergic diseases atopic eczema Biological and medical sciences Cadherins - genetics Cadherins - metabolism Calpain - genetics Cathepsin B - genetics Cathepsin D - genetics Cathepsin L - genetics Cell Adhesion Molecules - genetics Cell Differentiation - genetics Cell Line Cells, Cultured Claudins - genetics Cytoskeletal Proteins - genetics Dermatology Down-Regulation - genetics epidermal barrier filaggrin gamma Catenin - genetics gamma Catenin - metabolism Gene Expression - drug effects Gene Expression - genetics Humans IL-17 Immunopathology Interleukin-17 - pharmacology Intermediate Filament Proteins - genetics Intermediate Filament Proteins - metabolism keratinocytes Keratinocytes - drug effects Keratinocytes - metabolism Medical sciences Membrane Proteins - genetics Membrane Proteins - metabolism Oligonucleotide Array Sequence Analysis Phosphoproteins - genetics Phosphoproteins - metabolism S100 Proteins - genetics Skin allergic diseases. Stinging insect allergies Up-Regulation - genetics Zonula Occludens-1 Protein Zonula Occludens-2 Protein |
Title | IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion |
URI | https://api.istex.fr/ark:/67375/WNG-8ZM2TW8D-6/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1600-0625.2011.01412.x https://www.ncbi.nlm.nih.gov/pubmed/22229441 https://search.proquest.com/docview/1753471420 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQkRAXKN-hUBkJccsqduI4OVZsS0FsD6hVV1wsOxkvq0VetB_Swqk_gd_IL2EmyS4E9YAQlyiK7CgZz9hv7Odnxl56pzRIiYHkyjTOdJrHpbRJLLxM89pZAE27kUdn-elF9m6sxh3_ifbCtPoQuwk3ioymv6YAt27ZD_KcdkUjgO-UOEUm5IDwpEg1sbuGH3ZKUkKnjeZuUmICnetE9Uk9176oN1LdJKNviDlpl2g83556cR0s7aPcZpg6uctm2x9s2SmzwXrlBtW3P7Qf_48F9tmdDs3yo9b97rEbEO6zW6Nuvf4BC2_f_7j6LjSvMdlftMfew5L76Wc7mSymgdtQc9tSSviM9J2nYV59XQGHTcfQDXzu-YR6ZG47V4Ka0_Qxp0UHYtFyW38CKvqQXZwcn78-jbsTHuIKkaOMU7CuJEmxKpO-QG9KFBCtFWSN46RSPrc1epO0WvvM1aBTKIWrsaxHHFdW6SO2F-YBnjBeWky9isyKwiu8VlZKl0ApC-8yzCkhYmLbmuZLK-RhfkuA0JCGDGnIkKYxpNlE7FXT7LsKdjEjIpxW5vLsjSk-juT5ZTE0ecQOe36xq4AJm8ZvUBF7sXUUg_FL9rEB5uulIaVUBAiZTCL2uPWgX7XpsHXEqxHLGz_46w83x-Mh3T3914oH7DY-li09_RnbWy3W8BzR18odNnH1E7jfIOs |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEB6hXQm48GYJj8VIiFuqxHk4OSK6SxfaHlBXW3Gx7GRcqq5S1IdUOPET-I38EmaStFC0B4S4RDnYkTOZsb9xPn8D8NLZRKGUFEg2j_xYRamfSxP4oZNRWlqDqPg08mCY9s7jd-Nk3JYD4rMwjT7EbsONI6OerznAeUN6P8pTPhZNCL6V4gzjUHYIUB5S9Edcx6H7YaclFaqoVt0NckqhUxUk-7SeK5-0t1Ydstk3zJ00SzKfa-peXAVM93FuvVCd3obL7Ss2_JRZZ72yneLrH-qP_8kGd-BWC2jF68YD78I1rO7B9UH7y_4-VGf9H9--h0qUlO8vmsr3uBRuemkmk8W0EqYqhWlYJWLGEs_Tal58WaHATUvSrcTciQlPysK03oSl4B1kwf8dmEgrTPkJuekDOD89Gb3p-W2RB78g8Cj9CI3NWVWsiKXLyKGCBJnZirKkpTJJXGpKcihplHKxLVFFmIe2pLaOoFxeRA_hoJpX-AhEbij7ymITZi6ha2GktAHmMnM2prQSPQi3n1N_brQ89G85EBlSsyE1G1LXhtQbD17V333XwSxmzIVTib4YvtXZx4EcXWRdnXpwvOcYuw6UsykaQ-LBi62naAphto-pcL5eahZLJYwQy8CDo8aFfvXmeusEWT1Ia0f464Hrk3GX7x7_a8fncKM3GvR1_2z4_gncpCayYas_hYPVYo3PCIyt7HEdZD8BujElAw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEB6hXWnFhfcjPBYjIW6pEieOkyOiW3ZhWyG0q624WHZsl6ooXfUhFU78BH4jv4SZJC0E7QEhLlEOduSMZ-xv7M-fAV54I6TjHAPJFEmYyiQLC66jMPY8yazRzkk6jTwcZcfn6duxGLf8JzoL0-hD7BbcKDLq8ZoC_NL6bpBndCoaAXyrxBmnMe8hntxPMwTCBJA-7KSkYpnUortRgRl0JiPRZfVc-aXOVLVPVt8QdVIv0Xq-ufbiKlzahbn1PDW4CbPtHzb0lFlvvTK98usf4o__xwS34EYLZ9mrxv9uwzVX3YGDYbthfxeqk9Mf377HklnM9hfNvfduyfz0s55MFtOK6coy3XBK2IwEnqfVvPyycsxtWopuxeaeTWhIZrr1JWcZrR8z2nUgGi3T9pOjovfgfHB09vo4bK94CEuEjjxMnDYFaYqVKfc5ulMkHPFaHbc4UQrhM23RnbiW0qfGOpm4IjYWy3oEckWZ3Ie9al65h8AKjblXnuo49wKfpebcRK7guTcpJpUugHjbm-qyUfJQv2VAaEhFhlRkSFUbUm0CeFl3-66CXsyICSeFuhi9UfnHIT-7yPsqC-Cw4xe7CpixSWyDCOD51lEUBjDZR1duvl4qkkpFhJDyKIAHjQf9qk23rSNgDSCr_eCvG66Oxn16e_SvFZ_Bwfv-QJ2ejN49hutYgjdU9Sewt1qs3VNEYitzWIfYTyCpI7I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-17+downregulates+filaggrin+and+affects+keratinocyte+expression+of+genes+associated+with+cellular+adhesion&rft.jtitle=Experimental+dermatology&rft.au=Gutowska-Owsiak%2C+Danuta&rft.au=Schaupp%2C+Anna+L.&rft.au=Salimi%2C+Maryam&rft.au=Selvakumar%2C+Tharini+A.&rft.date=2012-02-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0906-6705&rft.eissn=1600-0625&rft.volume=21&rft.issue=2&rft.spage=104&rft.epage=110&rft_id=info:doi/10.1111%2Fj.1600-0625.2011.01412.x&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_8ZM2TW8D_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6705&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6705&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6705&client=summon |